Medicine · 2025
A meta-analysis of the effects of proton pump inhibitors on the risk of gastric cancer.
СтатьяМетаанализНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Hao, Meng Xianyu, Gou Dongyun, Liu Xiaojing, Huang Yu, Liu Siyu, Wang Haiyang, Li Hongyan
Аннотация
BACKGROUND: Proton pump inhibitors (PPIs) are commonly prescribed drugs in clinical practice, mainly for the treatment of Helicobacter pylori infection and gastroesophageal reflux disease (GERD). With the application of PPIs, doctors have found a variety of adverse reactions related to it, with gastric cancer being the most serious. Our aim is to investigate whether the use of PPIs increases the probability of gastric cancer.
METHODS: By searching PubMed, EMBASE, the Cochrane Library and Web of science, references related to PPIs and gastric cancer were selected, and Newcastle-Ottawa scale (NOS) was used to evaluate the quality of the included references and analyze their bias. Then stataSE-64 was used for statistical analysis. The above processes were independently searched and evaluated by 2 researchers.
RESULTS: The use of PPIs significantly increased the incidence of gastric cancer (RR = 1.75, 95% CI: 1.48-2.07, P = .000).
CONCLUSION: Long-term use of PPIs may increase the incidence of gastric cancer.
METHODS: By searching PubMed, EMBASE, the Cochrane Library and Web of science, references related to PPIs and gastric cancer were selected, and Newcastle-Ottawa scale (NOS) was used to evaluate the quality of the included references and analyze their bias. Then stataSE-64 was used for statistical analysis. The above processes were independently searched and evaluated by 2 researchers.
RESULTS: The use of PPIs significantly increased the incidence of gastric cancer (RR = 1.75, 95% CI: 1.48-2.07, P = .000).
CONCLUSION: Long-term use of PPIs may increase the incidence of gastric cancer.